Filing Details
- Accession Number:
- 0001375151-20-000004
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-01-10 16:15:19
- Reporting Period:
- 2020-01-08
- Accepted Time:
- 2020-01-10 16:15:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1375151 | Zogenix Inc. | ZGNX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1247666 | J Stephen Farr | C/O Zogenix, Inc. 5959 Horton Street, Suite 500 Emeryville CA 94608 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-01-08 | 29,559 | $10.35 | 86,267 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-01-08 | 4,666 | $10.64 | 90,933 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-01-08 | 28,955 | $51.83 | 61,978 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-08 | 5,270 | $52.20 | 56,708 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-01-08 | 29,559 | $0.00 | 29,559 | $10.35 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-01-08 | 4,666 | $0.00 | 4,666 | $10.64 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 100,428 | 2026-03-13 | No | 4 | M | Direct | |
| 26,583 | 2025-03-17 | No | 4 | M | Direct |
Footnotes
- The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
- Includes 181 shares acquired under the Company's Employee Stock Purchase Plan since the last Section 16 filing by the Reporting Person.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.28 to $51.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.00 to $52.54, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The option was granted on March 14, 2016 and vests in a series of forty-eight (48) successive, equal monthly installments measured from the date of grant, subject to the Reporting Person's continuous service to the Company on each vesting date.
- The Option was granted on March 17, 2015 and vests in a series of forty-eight (48) successive, equal monthly installments measured from the date of grant, subject to the Reporting Person's continued service to the Company on each vesting date.
Billionaire Hedge Funds
